Type 1 Hyperlipoprotenemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Type 1 Hyperlipoprotenemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05816343

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high.…

United States28 participantsStarted 2024-01-26

Treatment: Orlistat, Placebo

Type 1 Hyperlipoprotenemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

All recent trials (1 shown)